Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.170
+0.070 (3.33%)
May 7, 2025, 4:00 PM - Market closed
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $138.94 million as of May 8, 2025. Its market cap has decreased by -66.65% in one year.
Market Cap
138.94M
Enterprise Value
-13.72M
1-Year Change
-66.65%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since June 19, 2014, Larimar Therapeutics's market cap has decreased from $410.90M to $138.94M, a decrease of -66.19%. That is a compound annual growth rate of -9.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2025 | 134.50M | -45.52% |
| Dec 31, 2024 | 246.90M | 23.57% |
| Dec 29, 2023 | 199.80M | 11.81% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.80M | 692.29% |
| Dec 31, 2019 | 41.50M | -77.26% |
| Dec 31, 2018 | 182.50M | 43.70% |
| Dec 29, 2017 | 127.00M | 46.14% |
| Dec 30, 2016 | 86.90M | -49.27% |
| Dec 31, 2015 | 171.30M | -75.54% |
| Dec 31, 2014 | 700.30M | 70.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.03B |
| Johnson & Johnson | 374.29B |
| UnitedHealth Group | 363.81B |
| AbbVie | 335.69B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 230.79B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |